{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:36:05Z","timestamp":1791221765254,"version":"4.1.0"},"reference-count":41,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1645,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1365-2710.2010.01166.x","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T17:56:04Z","timestamp":1276106164000},"page":"152-160","source":"Crossref","is-referenced-by-count":29,"title":["Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology"],"prefix":"10.1155","volume":"36","author":[{"given":"B.","family":"des Champs-Bro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Leroy-Cotteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mazingue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Corm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alfandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sendid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bmt.1703732","article-title":"Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies","volume":"30","author":"Safdar","year":"2002","journal-title":"Bone Marrow Transplantation"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CMR.9.4.499","article-title":"Epidemiology of nosocomial fungal infections","volume":"9","author":"Fridkin","year":"1996","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.ejca.2008.07.008","article-title":"The First European Conference on Infections in Leukaemia - ECIL1: A current perspective","volume":"44","author":"Meunier","year":"2008","journal-title":"European Journal of Cancer"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB6|cit6","first-page":"175S","article-title":"A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines","volume":"21","author":"Kontoyiannis","year":"2001","journal-title":"Infectious Diseases Society of America Pharmacotherapy"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis","volume":"30","author":"Rex","year":"2000","journal-title":"Infectious Diseases Society of America Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","article-title":"Practice guidelines for diseases caused by Aspergillus","volume":"30","author":"Stevens","year":"2000","journal-title":"Infectious Diseases Society of America Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.medmal.2005.01.004","article-title":"[Management of aspergillosis in immunocompromised patients. Recommendations of Lille University Hospital. 4th version. November 2004]","volume":"35","author":"Alfandari","year":"2005","journal-title":"M\u00e9decine et Maladies Infectieuses"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997","volume":"33","author":"McNeil","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0163-4453(98)80173-4","article-title":"An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group","volume":"37","author":"Denning","year":"1998","journal-title":"Journal of Infection"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients","volume":"116","author":"Martino","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.leu.2403674","article-title":"Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies","volume":"19","author":"Muhlemann","year":"2005","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB16|cit16","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1469-0691.2002.00446.x","article-title":"Candidemia in French hospitals: incidence rates and characteristics","volume":"8","author":"Richet","year":"2002","journal-title":"Clinical Microbiology Infection"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB19|cit19","first-page":"523","article-title":"[Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004]","volume":"54","author":"Eloy","year":"2006","journal-title":"Pathology Biology (Paris)"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB20|cit20","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"49","author":"Sendid","year":"2000","journal-title":"MMWR Recommendations and Reports"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-6-80","article-title":"Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links","volume":"6","author":"Sendid","year":"2006","journal-title":"BMC Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.medmal.2005.12.003","article-title":"[Pulmonary zygomycosis in a patient treated for invasive aspergillosis]","volume":"36","author":"Tricot","year":"2006","journal-title":"M\u00e9decine et Maladies Infectieuses"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.diagmicrobio.2004.08.015","article-title":"Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies","volume":"51","author":"Prella","year":"2005","journal-title":"Diagnostic Microbiology Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2141.2003.04308.x","article-title":"Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis","volume":"121","author":"Becker","year":"2003","journal-title":"British Journal of Haematology"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2710.2010.01166.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1080\/13693780400019990","article-title":"Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients","volume":"43","author":"Bow","year":"2005","journal-title":"Medical Mycology"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bmt.1704603","article-title":"Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients","volume":"34","author":"Hamza","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2006.01.018","article-title":"Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis","volume":"55","author":"Siwek","year":"2006","journal-title":"Diagnostic Microbiology Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/S1413-86702002000300004","article-title":"Emergence of resistant Candida in neutropenic patients","volume":"6","author":"Nucci","year":"2002","journal-title":"Brazilian Journal Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplantation"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group","volume":"86","author":"Pappas","year":"1989","journal-title":"The American Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0929-693X(07)78702-X","article-title":"[Antifungal therapy in children: new topics and prospects]","volume":"14","author":"Le Guyader","year":"2007","journal-title":"Archives of Paediatrics"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.27.3.369","article-title":"The echinocandins","volume":"27","author":"Cappelletty","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.46.9.3039-3041.2002","article-title":"In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp","volume":"46","author":"Perea","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/pbc.20302","article-title":"Successful antifungal combination therapy with voriconazole and caspofungin","volume":"44","author":"Schuster","year":"2005","journal-title":"Pediatrics Blood and Cancer"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00520-006-0137-3","article-title":"Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection","volume":"15","author":"Klastersky","year":"2007","journal-title":"Supportive Care in Cancer"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB40|cit40","first-page":"69","article-title":"Complications infectieuses des h\u00e9mopathies","volume":"13","author":"Cordonnier","year":"2007","journal-title":"Hematologie"},{"key":"10.1111\/j.1365-2710.2010.01166.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2006.00123.x","article-title":"Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy","volume":"8","author":"de Pauw","year":"2006","journal-title":"Transplant Infectious Disease"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2010.01166.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2010.01166.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:41Z","timestamp":1671818621000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2010.01166.x"}},"subtitle":["Invasive fungal infections: analysis of antifungal prescriptions"],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2010.01166.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}